5RUGGE M, CORREA P, DIXON MF, et al. Gastric muco- sal atrophy: interobserver consistency using new criteria for classification and grading [J]. Aliment Pharmacol Ther, 2002,16(7) : 1249 - 1259.
7Peterson DE,Bensadoun RJ,Roila F.Management of oral and gastrointestinal mucositis:ESMO Clinical Practice Guide- lines [ J ].Ann Oncol, 2011,22 (6) : 78-84.
8Lalla RV, Bowen J, Barasch A, et al.MASCC/ISOO clinical practice guidelines for the management of mucositis sec- ondary to cancer therapy [ J ].Cancer, 2014, 120 ( 10 ) : 1453- 1461.
9Stringer AM, Gibson RJ, Bowen JM, et al.Chemotherapy-in- duced modifications to gastrointestinal microflora: evidence and implications of change [ J ].Curr Drug Metab, 2009,10 ( 1 ) : 79-83.
10Sonis S, Haddad R, Posner M, et al.Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers [J].Oral Oncol, 2007,43 (3) : 289-300.
